glp 1 suicide and suicide attempt in users of GLP-1 receptor agonists: a nationwide case-time-control study GLP-1 drugs and suicidal ideation:
Description
Vasodilator effect of glucagon: Receptorial crosstalk among glucagon, GLP-1, and receptor for glucagon and GLP-1

Tirzepatide , a dual GLP-1/GIP receptor agonist, has been approved by NICE for type 2 diabetes management

,

So the question is: Is there going to be increased pressure on the starting doses of tirzepatide and semaglutide? The restrictions on compounded GLP-1 products come as concerns about existing shortages are bubbling

doi:10.1210/en.2009-1197 251

Wright AK, Carr MJ, Kontopantelis E, et al